Issue Price
₹27
Per Share
GMP
NIL
Grey Market
Est. Listing
₹27
Expected Price
Min. Application
₹216,000
2 lots × 4000 shares
Evoq Remedies Ltd. is proposing an Initial Public Offering (IPO) on the BSE SME platform under the SME category.
Subscription opens 17 Mar 2022, closes 22 Mar 2022. Listing expected 30 Mar 2022. Apply via ASBA or UPI.
Evoq Remedies Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹108,000 |
| Retail (Max) | 13 | 52,000 | ₹1,404,000 |
| sNII (Min) | 14 | 56,000 | ₹1,512,000 |
| bNII (Min) | 68 | 272,000 | ₹7,344,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |